Skip to main content
Screener/Healthcare/Biotechnology

BCAX — Bicara Therapeutics Inc. Common Stock

NASDAQ
$9.92-7.52 (-43.02%)
$8.90
$30.99
$8.90
$17.57
EPS (TTM)$-2.78
P/E Ratio-8.76
Dividend Yield—
Market Cap$1.16B
Volume13.18M
Prev Close$17.48
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$56.2M$-0.93——
Q4 '25$0-$37.4M$-0.68——
Q3 '25$0-$36.3M$-0.67——
Q2 '25$0-$27.4M$-0.50——
Q1 '25$0-$36.8M$-0.68——
Q4 '24$0-$21.0M$-0.38——
Q3 '24$0-$17.5M$-0.32——
Q2 '24$0-$17.0M$-0.27——
Get Your Daily Market Recap